Shenyu Communication Technology Inc. (300563.SZ) has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds.
Shenyu Co., Ltd. (300563.SZ) released an announcement stating that the company recently received a document from the China Securities Regulatory Commission...
Shenyu Communication Technology Inc. (300563.SZ) announced that the company has recently received the approval from the China Securities Regulatory Commission for the registration of issuing convertible corporate bonds to unspecified investors. The approval allows the company to go ahead with the registration application for issuing convertible corporate bonds to unspecified investors.
Related Articles
Shenzhen Kangtai Biological Products (300601.SZ): Quadrivalent split influenza vaccine (6-35 months old population) initiates Phase I clinical trial.
Goldwind Science & Technology (02208) received 40,954,200 shares from its shareholder Harmony Health through reduction of A shares.
Focused Photonics (300203.SZ) has repurchased 1.28% of its shares, costing 107 million yuan.
Shenzhen Kangtai Biological Products (300601.SZ): Quadrivalent split influenza vaccine (6-35 months old population) initiates Phase I clinical trial.
Goldwind Science & Technology (02208) received 40,954,200 shares from its shareholder Harmony Health through reduction of A shares.
Focused Photonics (300203.SZ) has repurchased 1.28% of its shares, costing 107 million yuan.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
